Project Grant HT94252310207
Award Date
8/1/23
Completion Date
7/31/27
Dollars Obligated
$926K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Pennsylvania, USA
Similar Awards
The University of Pittsburgh was awarded a $954,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support research from May 2023 to May 2026 aimed at epigenetic reprogramming to target senescent ovarian cancer cells and overcome therapeutic resistance. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
The University of Pittsburgh has been awarded a $1,541,823 Project Grant from the Department of the Army Medical Command's Military Medical Research and Development federal grant program (CFDA 12.420) to develop fast treatment methods for metastatic cancer patients with pleural disease. The grant, which runs from November 1, 2024 to October 31, 2028, will fund the University's research efforts to explore innovative approaches to disease prevention, diagnosis, treatment, and management of these...
The University of Pittsburgh received a $454,142.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "FERROPTOSIS AS A METABOLIC VULNERABILITY OF CYCLIN E-HIGH OVARIAN CANCER". This 2-year research project, with a performance period from May 2024 to May 2026, aims to investigate metabolic vulnerabilities in a specific type of ovarian cancer. The University of Pittsburgh is the primary...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $4,902,315.00 in funding to the University of Pittsburgh to conduct research on understanding the effects of intracavitary conditioning in breast cancer metastatic to the pleura or the peritoneum. The award, which began on June 1, 2025 and is scheduled for completion on May 31, 2029, supports advanced biomedical research focused on transforming...
The University of Pittsburgh - Of The Commonwealth System of Higher Education, doing business as The University of Pittsburgh, was awarded a $636,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research on a novel combination therapy targeting growth factor receptor cross talk with epitranscriptomic regulation in glioblastoma, a type of brain cancer, with the goal of developing innovative medical...
The University of Pittsburgh was awarded a $795,001 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The three-year award will fund a research project from September 2022 to August 2025 to interrogate the impact of B cells and tertiary lymphoid structures in melanoma brain metastases. Through this funding, the University of Pittsburgh will investigate medical solutions for the battlefield by supporting applied and advanced...
The University of Pittsburgh was awarded a $721,250 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The three-year grant will fund research on Programmed Cell Death 6 Interacting Protein (PDCD6IP) in plasma-derived exosomes as a potential prognostic biomarker of melanoma progression. Through September 2025, researchers at the University of Pittsburgh will investigate medical solutions for the...
The University of Pittsburgh - Of the Commonwealth System of Higher Education (University of Pittsburgh) was awarded a $1,246,455 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will support research to characterize a novel class of non-competitive androgen receptor antagonists from May 15, 2023 to May 14, 2026. The Military Medical Research and Development program aims to transform military and public health...
The University of Pittsburgh has been awarded a $681,379 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to evaluate B-T cell cross talk within tertiary lymphoid structures in melanoma progression and immune checkpoint blockade. The award has a performance period from July 1, 2024 to June 30, 2027. This research project aims to enhance understanding of the immune processes involved in melanoma development and response to...
This $1,264,474 federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports the University of Pittsburgh's research on "Molecular Insights into Immune Suppression in Kidney Cancer and Novel Therapeutic Opportunities". The grant, effective September 1, 2024 through August 31, 2028, will fund the university's investigations into improving understanding of immune system mechanisms involved in kidney cancer and...